Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 22, 2022 - Issue 11
Submit an article Journal homepage
1,424
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Analytical comparability demonstrated for an IgG4 molecule, inclacumab, following transfer of manufacturing responsibility from Roche to Global Blood Therapeutics

Radu Mihailaa Global Blood Therapeutics, South San Francisco, CA, USACorrespondence[email protected]
View further author information
,
Dipali Ruhelaa Global Blood Therapeutics, South San Francisco, CA, USAView further author information
,
Lifang Xua Global Blood Therapeutics, South San Francisco, CA, USAView further author information
,
Sandra Joussefa Global Blood Therapeutics, South San Francisco, CA, USAView further author information
,
Xin Genga Global Blood Therapeutics, South San Francisco, CA, USAView further author information
,
Jianxia Shia Global Blood Therapeutics, South San Francisco, CA, USAView further author information
,
Andrea S. Kima Global Blood Therapeutics, South San Francisco, CA, USAView further author information
,
Wendy Yaresa Global Blood Therapeutics, South San Francisco, CA, USAView further author information
,
Kevin Furstossa Global Blood Therapeutics, South San Francisco, CA, USAView further author information
&
Kent Iversonb Kent Iverson Consulting, Sonoma, CA, USAView further author information
 show all
Pages 1417-1428 | Received 29 Sep 2022, Accepted 31 Oct 2022, Published online: 09 Nov 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.